Physician profile

Jawad Kiani

Cardiovascular Disease · Las Vegas, NV

NPI 1588975544

$73,097.83

in general payments reported to CMS, 2019-2025

24 companies · $38K in 2025

The $38K reported for 2025 was more than what 98% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

See the full distribution for Cardiovascular Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Grant$33,750.00
Food and Beverage$6,355.05
Travel and Lodging$6,018.40
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$5,160.00
Consulting Fee$3,487.50
Education$129.46

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $40,364.32 2020-2025 Mitraclip, Triclip, Xact
Edwards Lifesciences Corporation $12,736.89 2019-2025 Edwards Sapien 3 Ultra Transcatheter Heart Valve, Evoque, Edwards Sapien 3 Transcatheter Heart Valve (Thv)
Boston Scientific Corporation $6,912.97 2019-2024 Watchman Flx, Baylis Medical Company Radiofrequency Puncture Generator
Penumbra, INC. $2,788.78 2020-2024 Indigo System
Angiodynamics, INC. $2,469.04 2022
Medtronic, INC. $2,100.00 2021-2024 Valiant Captivia, Corevalve Evolut R, Endurant Iis
Abiomed $1,297.90 2019-2021
Medtronic Vascular, INC. $972.78 2019-2020
Baylis Medical Company INC $780.20 2019
W. L. Gore & Associates, INC. $575.55 2021-2024 Gore Cardioform Septal Occluder, Gore Viabahn Vbx Balloon Expandable Endo
Shockwave Medical, INC $385.66 2022
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $278.65 2021-2025 Lifevest
Siemens Medical Solutions USA, INC. $262.92 2019-2022
Impulse Dynamics (USA) INC. $236.90 2023 Optimizer
Biosense Webster, INC. $219.40 2021
Show all 24 companies
CompanyGeneral paymentsYearsTop products
Cvrx, INC. $195.38 2024 Barostim Neo System
Stryker Corporation $168.51 2025 Flowtriever
Janssen Pharmaceuticals, INC $106.98 2022-2023 Xarelto
Chiesi USA, INC. $83.64 2023 Kengreal
Amgen INC. $76.94 2021
Novartis Pharmaceuticals Corporation $26.64 2024
Surmodics, INC. $22.24 2024 Pounce Venous Thrombectomy System
Cardiovascular Systems INC. $18.21 2021
Philips North America LLC $17.33 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Jawad Kiani

$73,097.83

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbott Laboratories
Context
The $38K reported for 2025 was more than what 98% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/117106/jawad-kiani

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.